ETF Holdings Breakdown of LYEL

Stock NameLyell Immunopharma Inc
TickerLYEL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS55083R1041

News associated with LYEL

Lyell Immunopharma, Inc. (NASDAQ:LYEL) Shares Purchased by Geode Capital Management LLC
Geode Capital Management LLC raised its position in Lyell Immunopharma, Inc. (NASDAQ:LYEL – Free Report) by 2.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 4,137,264 shares of the company’s stock after acquiring an additional 117,303 shares during the quarter. Geode Capital Management LLC’s holdings in Lyell Immunopharma were worth $2,648,000 as of […] - 2025-04-29 07:30:48

LYEL institutional holdings

The following institutional investment holdings of LYEL have been identified

Date ETF ISIN/Name Num Shares Book value
2024-11-25 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 65,218 -299.3%USD 59,538 -315.5%
2025-05-12 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 230,285USD 97,088
2025-05-12 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 127,776USD 53,870
2025-05-12 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 127,776USD 53,870 5.1%
2024-11-12 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 6,194USD 7,216
Total =557,249 USD 271,582
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.